Clinical Trials
2 trialsNCT00851045 2015-10-12
Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer
Bristol-Myers Squibb
Phase 2 Completed
NCT00374179 2009-02-24
CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma
Adnexus, A Bristol-Myers Squibb R&D Company
Phase 1 Completed